Sectors
LONA
Athira Pharma, Inc.
8.09
1 x 7.30
1 x 8.14
bid
ask
+
0.11
1.38%
11:16 AM
timesize
| Ytd | 23.51% | |
| 1y | 23.51% |
7.79
day range
8.00
4.25
52 week range
11.91
| Open | 7.90 | Prev Close | 7.98 | Low | 7.79 | High | 8.00 | Mkt Cap | 31.47M |
| Vol | 1.60K | Avg Vol | 0.00 | EPS | -25.19 | P/E | -0.32 | Forward P/E | N/A |
| Beta | 2.01 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 6.75 | 200-d Avg | 6.75 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 17.21M | ||
| Research and Development Expense | 11.26M | ||
| Selling, General and Administrative Expense | 6.88M | ||
| Operating Income | -17.21M | ||
| Net Income | -32.95M | ||
| Net Income Common Stock | -32.95M | ||
| Net Income Common Stock (USD) | -32.95M | ||
| Consolidated Income | -32.95M | ||
| Earnings per Basic Share | -1.73 | ||
| Earnings per Basic Share (USD) | -1.73 | ||
| Earnings per Diluted Share | -1.73 | ||
| Earning Before Interest & Taxes (EBIT) | -32.95M | ||
| Earning Before Interest & Taxes (USD) | -32.95M | ||
| Weighted Average Shares | 19.03M | ||
| Weighted Average Shares Diluted | 19.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 33.46M | ||
| Cash and Equivalents (USD) | 33.46M | ||
| Investments | 34.85M | ||
| Investments Current | 34.85M | ||
| Current Assets | 69.20M | ||
| Property, Plant & Equipment Net | 1.70M | ||
| Total Assets | 71.59M | ||
| Debt Current | 478.00K | ||
| Total Debt | 691.00K | ||
| Current Liabilities | 6.67M | ||
| Debt Non-Current | 213.00K | ||
| Total Liabilities | 22.29M | ||
| Accumulated Retained Earnings (Deficit) | -544.70M | ||
| Accumulated Other Comprehensive Income | -13.00K | ||
| Shareholders Equity | 49.30M | ||
| Shareholders Equity (USD) | 49.30M | ||
| Assets Non-Current | 2.39M | ||
| Total Debt (USD) | 691.00K | ||
| Liabilities Non-Current | 15.62M | ||
| Trade and Non-Trade Payables | 1.76M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 305.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -36.44M | ||
| Net Cash Flow from Investing | -15.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -15.54M | ||
| Net Cash Flow from Operations | -20.90M | ||
| Share Based Compensation | 662.00K | ||